Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less

Neonatal hippocampal lesions in rats produce behavioral and neurochemical abnormalities post-puberty that are used in animal models for developmentally linked pathology in schizophrenia. In one model, adult rats exhibit enhanced sensitivity to the locomotor-activating effects of amphetamine, if they...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research bulletin 2001-05, Vol.55 (1), p.71-77
Hauptverfasser: Swerdlow, N.R, Halim, N, Hanlon, F.M, Platten, A, Auerbach, P.P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 77
container_issue 1
container_start_page 71
container_title Brain research bulletin
container_volume 55
creator Swerdlow, N.R
Halim, N
Hanlon, F.M
Platten, A
Auerbach, P.P
description Neonatal hippocampal lesions in rats produce behavioral and neurochemical abnormalities post-puberty that are used in animal models for developmentally linked pathology in schizophrenia. In one model, adult rats exhibit enhanced sensitivity to the locomotor-activating effects of amphetamine, if they had sustained excitotoxic lesions of the ventral hippocampus on post-natal day 7. The hippocampal elements responsible for these lesion-induced developmental changes have not been fully characterized. The present study assessed the locomotor-activating effects of amphetamine in adult rats that on day 7 had sustained either sham or ibotenic acid lesions of the ventral hippocampus alone (“standard lesions”), or the ventral hippocampus plus surrounding portions of entorhinal cortex and dorsal hippocampus (“large lesions”). “Standard lesions” produced the expected “supersensitive” locomotor response to amphetamine, while “large lesions” did not. No differences between these lesion groups were observed in baseline levels of locomotor activity or habituation. These data suggest that models of enhanced behavioral sensitivity to dopamine agonists after neonatal hippocampal lesions require functionality in the entorhinal cortex and/or dorsal hippocampus. It is possible that the behavioral abnormalities in the “neonatal hippocampal lesion model” reflect, at least in part, aberrant function within spared elements of the hippocampal complex.
doi_str_mv 10.1016/S0361-9230(01)00492-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18092920</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0361923001004920</els_id><sourcerecordid>18092920</sourcerecordid><originalsourceid>FETCH-LOGICAL-c473t-11adf59253cea43256db350d4511bbd527e0754c35590b88ad855a279ec2077d3</originalsourceid><addsrcrecordid>eNqFkE1v1DAQhi0EotvCTwDlgBAcUmb8ESe9IFQVqLQSB-BsOfZEa5TEwc5Wan99k90VcOM0I-t5X48exl4hXCJg9eE7iArLhgt4B_geQDa8hCdsg7UWJddSP2WbP8gZO8_5FwBUtaqeszNEybWQsGF-SznEscjhgQo7-sIO045mO4SRit39RKmPLg5xXiHbzZSKkeJoZ9sXdzTOaZm7ME3RLcFl7w91-aoYYqIi5PUhv2DPOttnenmaF-zn55sf11_L7bcvt9eftqWTWswlovWdargSjqwUXFW-FQq8VIht6xXXBFpJJ5RqoK1r62ulLNcNOQ5ae3HB3h57pxR_7ynPZgjZUd_b5eZ9NlhDwxsOC6iOoEsx50SdmVIYbLo3CGbVaw56zerOAJqDXrPmXp8-2LcD-b-pk88FeHMCbHa275IdXcj_tEuUKBbs4xGjxcZdoGSyCzQ68iGRm42P4T-XPALVe5dB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18092920</pqid></control><display><type>article</type><title>Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Swerdlow, N.R ; Halim, N ; Hanlon, F.M ; Platten, A ; Auerbach, P.P</creator><creatorcontrib>Swerdlow, N.R ; Halim, N ; Hanlon, F.M ; Platten, A ; Auerbach, P.P</creatorcontrib><description>Neonatal hippocampal lesions in rats produce behavioral and neurochemical abnormalities post-puberty that are used in animal models for developmentally linked pathology in schizophrenia. In one model, adult rats exhibit enhanced sensitivity to the locomotor-activating effects of amphetamine, if they had sustained excitotoxic lesions of the ventral hippocampus on post-natal day 7. The hippocampal elements responsible for these lesion-induced developmental changes have not been fully characterized. The present study assessed the locomotor-activating effects of amphetamine in adult rats that on day 7 had sustained either sham or ibotenic acid lesions of the ventral hippocampus alone (“standard lesions”), or the ventral hippocampus plus surrounding portions of entorhinal cortex and dorsal hippocampus (“large lesions”). “Standard lesions” produced the expected “supersensitive” locomotor response to amphetamine, while “large lesions” did not. No differences between these lesion groups were observed in baseline levels of locomotor activity or habituation. These data suggest that models of enhanced behavioral sensitivity to dopamine agonists after neonatal hippocampal lesions require functionality in the entorhinal cortex and/or dorsal hippocampus. It is possible that the behavioral abnormalities in the “neonatal hippocampal lesion model” reflect, at least in part, aberrant function within spared elements of the hippocampal complex.</description><identifier>ISSN: 0361-9230</identifier><identifier>EISSN: 1873-2747</identifier><identifier>DOI: 10.1016/S0361-9230(01)00492-0</identifier><identifier>PMID: 11427340</identifier><identifier>CODEN: BRBUDU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic Uptake Inhibitors - pharmacology ; Adult and adolescent clinical studies ; Amphetamine ; Amphetamine - pharmacology ; Animals ; Animals, Newborn - growth &amp; development ; Animals, Newborn - metabolism ; Behavior, Animal - drug effects ; Behavior, Animal - physiology ; Biological and medical sciences ; Denervation ; Disease Models, Animal ; Entorhinal cortex ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - growth &amp; development ; Hippocampus - physiology ; Hyperkinesis - chemically induced ; Hyperkinesis - physiopathology ; Ibotenic acid ; Locomotion ; Medical sciences ; Nervous System Malformations - pathology ; Nervous System Malformations - physiopathology ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Rats ; Rats, Sprague-Dawley ; Schizophrenia ; Schizophrenia - etiology ; Schizophrenia - pathology ; Schizophrenia - physiopathology</subject><ispartof>Brain research bulletin, 2001-05, Vol.55 (1), p.71-77</ispartof><rights>2001 Elsevier Science Inc.</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c473t-11adf59253cea43256db350d4511bbd527e0754c35590b88ad855a279ec2077d3</citedby><cites>FETCH-LOGICAL-c473t-11adf59253cea43256db350d4511bbd527e0754c35590b88ad855a279ec2077d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0361-9230(01)00492-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1041413$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11427340$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swerdlow, N.R</creatorcontrib><creatorcontrib>Halim, N</creatorcontrib><creatorcontrib>Hanlon, F.M</creatorcontrib><creatorcontrib>Platten, A</creatorcontrib><creatorcontrib>Auerbach, P.P</creatorcontrib><title>Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less</title><title>Brain research bulletin</title><addtitle>Brain Res Bull</addtitle><description>Neonatal hippocampal lesions in rats produce behavioral and neurochemical abnormalities post-puberty that are used in animal models for developmentally linked pathology in schizophrenia. In one model, adult rats exhibit enhanced sensitivity to the locomotor-activating effects of amphetamine, if they had sustained excitotoxic lesions of the ventral hippocampus on post-natal day 7. The hippocampal elements responsible for these lesion-induced developmental changes have not been fully characterized. The present study assessed the locomotor-activating effects of amphetamine in adult rats that on day 7 had sustained either sham or ibotenic acid lesions of the ventral hippocampus alone (“standard lesions”), or the ventral hippocampus plus surrounding portions of entorhinal cortex and dorsal hippocampus (“large lesions”). “Standard lesions” produced the expected “supersensitive” locomotor response to amphetamine, while “large lesions” did not. No differences between these lesion groups were observed in baseline levels of locomotor activity or habituation. These data suggest that models of enhanced behavioral sensitivity to dopamine agonists after neonatal hippocampal lesions require functionality in the entorhinal cortex and/or dorsal hippocampus. It is possible that the behavioral abnormalities in the “neonatal hippocampal lesion model” reflect, at least in part, aberrant function within spared elements of the hippocampal complex.</description><subject>Adrenergic Uptake Inhibitors - pharmacology</subject><subject>Adult and adolescent clinical studies</subject><subject>Amphetamine</subject><subject>Amphetamine - pharmacology</subject><subject>Animals</subject><subject>Animals, Newborn - growth &amp; development</subject><subject>Animals, Newborn - metabolism</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavior, Animal - physiology</subject><subject>Biological and medical sciences</subject><subject>Denervation</subject><subject>Disease Models, Animal</subject><subject>Entorhinal cortex</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - growth &amp; development</subject><subject>Hippocampus - physiology</subject><subject>Hyperkinesis - chemically induced</subject><subject>Hyperkinesis - physiopathology</subject><subject>Ibotenic acid</subject><subject>Locomotion</subject><subject>Medical sciences</subject><subject>Nervous System Malformations - pathology</subject><subject>Nervous System Malformations - physiopathology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Schizophrenia</subject><subject>Schizophrenia - etiology</subject><subject>Schizophrenia - pathology</subject><subject>Schizophrenia - physiopathology</subject><issn>0361-9230</issn><issn>1873-2747</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v1DAQhi0EotvCTwDlgBAcUmb8ESe9IFQVqLQSB-BsOfZEa5TEwc5Wan99k90VcOM0I-t5X48exl4hXCJg9eE7iArLhgt4B_geQDa8hCdsg7UWJddSP2WbP8gZO8_5FwBUtaqeszNEybWQsGF-SznEscjhgQo7-sIO045mO4SRit39RKmPLg5xXiHbzZSKkeJoZ9sXdzTOaZm7ME3RLcFl7w91-aoYYqIi5PUhv2DPOttnenmaF-zn55sf11_L7bcvt9eftqWTWswlovWdargSjqwUXFW-FQq8VIht6xXXBFpJJ5RqoK1r62ulLNcNOQ5ae3HB3h57pxR_7ynPZgjZUd_b5eZ9NlhDwxsOC6iOoEsx50SdmVIYbLo3CGbVaw56zerOAJqDXrPmXp8-2LcD-b-pk88FeHMCbHa275IdXcj_tEuUKBbs4xGjxcZdoGSyCzQ68iGRm42P4T-XPALVe5dB</recordid><startdate>20010501</startdate><enddate>20010501</enddate><creator>Swerdlow, N.R</creator><creator>Halim, N</creator><creator>Hanlon, F.M</creator><creator>Platten, A</creator><creator>Auerbach, P.P</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7TK</scope></search><sort><creationdate>20010501</creationdate><title>Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less</title><author>Swerdlow, N.R ; Halim, N ; Hanlon, F.M ; Platten, A ; Auerbach, P.P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c473t-11adf59253cea43256db350d4511bbd527e0754c35590b88ad855a279ec2077d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adrenergic Uptake Inhibitors - pharmacology</topic><topic>Adult and adolescent clinical studies</topic><topic>Amphetamine</topic><topic>Amphetamine - pharmacology</topic><topic>Animals</topic><topic>Animals, Newborn - growth &amp; development</topic><topic>Animals, Newborn - metabolism</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavior, Animal - physiology</topic><topic>Biological and medical sciences</topic><topic>Denervation</topic><topic>Disease Models, Animal</topic><topic>Entorhinal cortex</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - growth &amp; development</topic><topic>Hippocampus - physiology</topic><topic>Hyperkinesis - chemically induced</topic><topic>Hyperkinesis - physiopathology</topic><topic>Ibotenic acid</topic><topic>Locomotion</topic><topic>Medical sciences</topic><topic>Nervous System Malformations - pathology</topic><topic>Nervous System Malformations - physiopathology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Schizophrenia</topic><topic>Schizophrenia - etiology</topic><topic>Schizophrenia - pathology</topic><topic>Schizophrenia - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swerdlow, N.R</creatorcontrib><creatorcontrib>Halim, N</creatorcontrib><creatorcontrib>Hanlon, F.M</creatorcontrib><creatorcontrib>Platten, A</creatorcontrib><creatorcontrib>Auerbach, P.P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><jtitle>Brain research bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swerdlow, N.R</au><au>Halim, N</au><au>Hanlon, F.M</au><au>Platten, A</au><au>Auerbach, P.P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less</atitle><jtitle>Brain research bulletin</jtitle><addtitle>Brain Res Bull</addtitle><date>2001-05-01</date><risdate>2001</risdate><volume>55</volume><issue>1</issue><spage>71</spage><epage>77</epage><pages>71-77</pages><issn>0361-9230</issn><eissn>1873-2747</eissn><coden>BRBUDU</coden><abstract>Neonatal hippocampal lesions in rats produce behavioral and neurochemical abnormalities post-puberty that are used in animal models for developmentally linked pathology in schizophrenia. In one model, adult rats exhibit enhanced sensitivity to the locomotor-activating effects of amphetamine, if they had sustained excitotoxic lesions of the ventral hippocampus on post-natal day 7. The hippocampal elements responsible for these lesion-induced developmental changes have not been fully characterized. The present study assessed the locomotor-activating effects of amphetamine in adult rats that on day 7 had sustained either sham or ibotenic acid lesions of the ventral hippocampus alone (“standard lesions”), or the ventral hippocampus plus surrounding portions of entorhinal cortex and dorsal hippocampus (“large lesions”). “Standard lesions” produced the expected “supersensitive” locomotor response to amphetamine, while “large lesions” did not. No differences between these lesion groups were observed in baseline levels of locomotor activity or habituation. These data suggest that models of enhanced behavioral sensitivity to dopamine agonists after neonatal hippocampal lesions require functionality in the entorhinal cortex and/or dorsal hippocampus. It is possible that the behavioral abnormalities in the “neonatal hippocampal lesion model” reflect, at least in part, aberrant function within spared elements of the hippocampal complex.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11427340</pmid><doi>10.1016/S0361-9230(01)00492-0</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0361-9230
ispartof Brain research bulletin, 2001-05, Vol.55 (1), p.71-77
issn 0361-9230
1873-2747
language eng
recordid cdi_proquest_miscellaneous_18092920
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adrenergic Uptake Inhibitors - pharmacology
Adult and adolescent clinical studies
Amphetamine
Amphetamine - pharmacology
Animals
Animals, Newborn - growth & development
Animals, Newborn - metabolism
Behavior, Animal - drug effects
Behavior, Animal - physiology
Biological and medical sciences
Denervation
Disease Models, Animal
Entorhinal cortex
Hippocampus
Hippocampus - drug effects
Hippocampus - growth & development
Hippocampus - physiology
Hyperkinesis - chemically induced
Hyperkinesis - physiopathology
Ibotenic acid
Locomotion
Medical sciences
Nervous System Malformations - pathology
Nervous System Malformations - physiopathology
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Rats
Rats, Sprague-Dawley
Schizophrenia
Schizophrenia - etiology
Schizophrenia - pathology
Schizophrenia - physiopathology
title Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T03%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lesion%20size%20and%20amphetamine%20hyperlocomotion%20after%20neonatal%20ventral%20hippocampal%20lesions:%20more%20is%20less&rft.jtitle=Brain%20research%20bulletin&rft.au=Swerdlow,%20N.R&rft.date=2001-05-01&rft.volume=55&rft.issue=1&rft.spage=71&rft.epage=77&rft.pages=71-77&rft.issn=0361-9230&rft.eissn=1873-2747&rft.coden=BRBUDU&rft_id=info:doi/10.1016/S0361-9230(01)00492-0&rft_dat=%3Cproquest_cross%3E18092920%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18092920&rft_id=info:pmid/11427340&rft_els_id=S0361923001004920&rfr_iscdi=true